Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-10-22

FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for fluoxetine from Teva Pharmaceuticals USA, Inc., indicating a modification to the product's approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine (Fluoxetine)

Snippet

SUPPL AP for FLUOXETINE (FLUOXETINE)